Bronchospasm News and Research

RSS
Almirall, Forest Laboratories' Tudorza Pressair now available in the U.S. pharmacies

Almirall, Forest Laboratories' Tudorza Pressair now available in the U.S. pharmacies

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

FDA approves Acton’s AEROSPAN sNDA to treat asthma

FDA approves Acton’s AEROSPAN sNDA to treat asthma

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

Merck welcomes launch of ROTATEQ in Rwanda of Africa’s rotavirus vaccination program

Merck welcomes launch of ROTATEQ in Rwanda of Africa’s rotavirus vaccination program

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB

FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB

CMS assigns J-code for Pharmaxis ARIDOL Bronchial Challenge Test Kit

CMS assigns J-code for Pharmaxis ARIDOL Bronchial Challenge Test Kit

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

The US Oncology Network affiliate treats advanced prostate cancer patients with PROVENGE

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

SYMBICORT long-term comparative study data in African American asthma patients presented at ATS 2011

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

POET-COPD study looks at controlling 'lung attacks' which can lead to increased ER visits

FDA approves Forest Labs' Daliresp to treat COPD

FDA approves Forest Labs' Daliresp to treat COPD